Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07084714 · ClinicalTrials.gov registry record · NA
Moderate Aerobic Exercise for Managing Menstrual Cycle Symptoms
A NA study of Premenstrual Syndrome and Menstrual Cycle, sponsored by University of Colorado, Colorado Springs.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT07084714: Recruiting NA study of Premenstrual Syndrome and Menstrual Cycle, sponsored by University of Colorado, Colorado Springs.
NCT07084714 is a NA study of Premenstrual Syndrome and Menstrual Cycle that is actively recruiting participants, run by University of Colorado, Colorado Springs. The registered enrollment target is 35 participants, below the 129-participant average among 6 other Premenstrual Syndrome trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07084714, a NA study of Premenstrual Syndrome and Menstrual Cycle, is actively recruiting participants, sponsored by University of Colorado, Colorado Springs.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the impact of moderate aerobic exercise on menstrual symptom management in sedentary women both using and not using hormonal contraceptives. The main questions it aims to answer are: Is there a reduction in physical and/or psychological menstrual cycle related symptom burden with participation in moderate aerobic exercise for sedentary women using and not using hormonal contraceptives? Is there a difference in physical and/or psychological menstrual cycle related symptom burden between hormonal contraceptive and non-hormonal contraceptive users? Is a moderate aerobic exercise intervention more effective in reducing physical and/or psychological menstrual related symptom burden for sedentary women using or not using hormonal contraceptives? Participants will: * Have their body composition assessed using dual energy X-ray absorptiometry pre and post exercise intervention. * Complete a Menstrual Symptom Index (MSi) to report daily menstrual cycle related symptom burden in addition to the Premenstrual Symptom Screening Tool (PSST) and Heavy Menstrual Bleeding (HMB) questionnaire monthly. * Utilize an at-home monitor to test urinary luteinizing hormone, estrone-3-glucuronide, and pregnanediol glucuronide approximately 10 times per month and report menstrual cycle length. * Record physical activity habits by continuously wearing a wrist-based accelerometer and chest-strap heart rate monitor during planned aerobic exercise sessions and complete the International Physical Activity Questionnaire (IPAQ) monthly. * Maintain their usual sedentary activity habits for one menstrual cycle followed by completion of an exercise intervention designed to progress individuals to meet minimum recommended aerobic physical activity guidelines of 150 minutes per week set by the American College of Sports Medicine for two menstrual cycles.
Primary Outcome
The MSi asks participants to report the intensity they are experiencing 18 menstrual related symptoms on a scale ranging from 0 = "do not feel at all" to 3 = "intense." A score of 0 indicates no symptom burden and 54 the maximum symptom burden.
Conditions Studied
Interventions
- BEHAVIORAL Moderate Aerobic Exercise
Study Locations (1)
Colorado
- William J. Hybl Sports Medicine and Performance Center - Colorado Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-07 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT07084714 shows while recruiting
NCT07084714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 129-participant average among 6 other Premenstrual Syndrome trials with a reported enrollment target (73% lower).
The record links to 4 conditions, with Premenstrual Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Moderate Aerobic Exercise is the first listed.
NCT07084714 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT07084714 about?
NCT07084714 is a clinical study titled "Moderate Aerobic Exercise for Managing Menstrual Cycle Symptoms". The goal of this clinical trial is to evaluate the impact of moderate aerobic exercise on menstrual symptom management in sedentary women both using and not using hormonal contraceptives. The main questions it aims to answer are: Is there a reduction in physical and/or psychological menstrual cycle...
What is the current status of trial NCT07084714?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2025-07. Estimated completion is 2026-08.
What conditions does trial NCT07084714 study?
This clinical trial studies the following conditions: Premenstrual Syndrome, Menstrual Cycle, Menstrual Bleeding, Heavy, Menstrual Distress (Dysmenorrhea).
What interventions are being tested in trial NCT07084714?
The interventions under investigation include: Moderate Aerobic Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT07084714?
This trial is sponsored by University of Colorado, Colorado Springs, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07084714 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premenstrual Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome
COMPLETED · NA
-
Effects of a Female Hormone Balance Supplement on Premenstrual Syndrome Symptoms
COMPLETED · NA
-
A Study to Evaluate the Effect of Funk It Cycle Bites on PMS
COMPLETED · NA
-
Identification and Validation of Epigenetic Biomarkers of PMDD
RECRUITING
-
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
COMPLETED · Phase 1
-
An Investigation Into the Efficacy of a Botanical Supplement to Provide Period Relief
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia